Antioxidant, Antidiabetic, Anticholinergic, and Antiglaucoma Effects of Magnofluorine

Abstract

Magnofluorine, a secondary metabolite commonly found in various plants, has pharmacological potential; however, its antioxidant and enzyme inhibition effects have not been investigated. We investigated the antioxidant potential of Magnofluorine using bioanalytical assays with 2,2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS•+), N,N-dimethyl-p-phenylenediamine dihydrochloride (DMPD•+), and 1,1-diphenyl-2-picrylhydrazyl (DPPH•) scavenging abilities and K3[Fe(CN)6] and Cu2+ reduction abilities. Further, we compared the effects of Magnofluorine and butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), α-Tocopherol, and Trolox as positive antioxidant controls. According to the analysis results, Magnofluorine removed 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals with an IC50 value of 10.58 μg/mL. The IC50 values of BHA, BHT, Trolox, and α-Tocopherol were 10.10 μg/mL, 25.95 μg/mL, 7.059 μg/mL, and 11.31 μg/mL, respectively. Our results indicated that the DPPH· scavenging effect of Magnofluorine was similar to that of BHA, close to that of Trolox, and better than that of BHT and α-tocopherol. The inhibition effect of Magnofluorine was examined against enzymes, such as acetylcholinesterase (AChE), α-glycosidase, butyrylcholinesterase (BChE), and human carbonic anhydrase II (hCA II), which are linked to global disorders, such as diabetes, Alzheimer’s disease (AD), and glaucoma. Magnofluorine inhibited these metabolic enzymes with Ki values of 10.251.94, 5.991.79, 25.411.10, and 30.563.36 nM, respectively. Thus, Magnofluorine, which has been proven to be an antioxidant, antidiabetic, and anticholinergic in our study, can treat glaucoma. In addition, molecular docking was performed to understand the interactions between Magnofluorine and target enzymes BChE (D: 6T9P), hCA II (A:3HS4), AChE (B:4EY7), and α-glycosidase (C:5NN8). The results suggest that Magnofluorine may be an important compound in the transition from natural sources to industrial applications, especially new drugs.

Antidiabetic activity of Berberis brandisiana is possibly mediated through modulation of insulin signaling pathway, inflammatory cytokines and adipocytokines in high fat diet and streptozotocin-administered rats

“…The DPPH has been widely used for the measurement of free radical scavenging activity of samples ( Durmaz et al, 2022 ; Gülçin et al, 2022 ). To prepare stock solution, 4 mg of DPPH was mixed in 100 mL of methanol.…”

“…Diabetes and obesity are the paramount recurrent endocrinemetabolic disorders that are categorized by hyperglycemia and impaired insulin secretion and/or its action (Kiziltas et al, 2022;Mutlu et al, 2023). Loss of β-cells function and impaired insulin secretion in obesity and diabetes results in persistent hyperglycemia and dyslipidemia (Eguchi et al, 2021).…”

Determination of Antioxidant, Anti-Alzheimer, Antidiabetic, Antiglaucoma and Antimicrobial Effects of Zivzik Pomegranate (Punica granatum)—A Chemical Profiling by LC-MS/MS

“…They also maintain fluid balance throughout the body, especially in the eyes, kidneys, and stomach. High intraocular pressure (IOP) due to glaucoma (IOP) can be relieved with the use of inhibitors of carbonic anhydrase (CAIs) [ 35 ].…”

Comprehensive Metabolite Profiling of Cinnamon (Cinnamomum zeylanicum) Leaf Oil Using LC-HR/MS, GC/MS, and GC-FID: Determination of Antiglaucoma, Antioxidant, Anticholinergic, and Antidiabetic Profiles

“…Thus, strategies to inhibit cholinergic acetylcholinesterase (AChE) in brain tissue have gained importance [ 24 , 25 ]. AChE, a hydrolytic enzyme, converts ACh to acetate and choline (Ch), whereas butyrylcholinesterase (BChE) converts butyrylcholine (BCh) to butyrate and Ch [ 26 ]. AD is clinically affected by brain tissue damage caused by ACh deficiency [ 27 ].…”